Overview
This session explores the intersection of translational research and innovation in advancing oral health, highlighting how emerging discoveries move from the laboratory to clinical practice. The discussion focuses on key advancements in oral health science, innovative treatment approaches, and the critical role of funding opportunities in fostering impactful research.
Learning Outcomes: Participants will gain:
- An understanding of the critical role translational research plays in advancing oral healthcare.
- Awareness of the latest innovations transforming the field of dentistry.
- Practical tips for accessing funding opportunities to support their research endeavors.
About Dr. Orlando Lopez
Dr. Orlando Lopez is the Director of the Dental Materials and Biomaterials Program at the National Institute of Dental and Craniofacial Research (NIDCR), part of the National Institutes of Health (NIH). In this role, he provides scientific leadership and strategic vision to strengthen a diverse national research agenda focused on basic science and translational research in biomaterials, biosensing, and digital technologies addressing unmet clinical needs in dental, oral, and craniofacial conditions.
Additionally, Dr. Lopez coordinates the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs at NIDCR, supporting technology innovation grants and fostering collaborations between small businesses and research institutions.
Before joining NIDCR, Dr. Lopez served as a lead regulatory reviewer at the FDA’s Center for Devices and Radiological Health (CDRH), where he led medical device approvals in imaging, cardiovascular, and digital health technologies. He holds a Ph.D. in Biomedical Engineering from the Mayo Clinic and a B.S. from Boston University.